Connection

Mark Rubinstein to Class I Phosphatidylinositol 3-Kinases

This is a "connection" page, showing publications Mark Rubinstein has written about Class I Phosphatidylinositol 3-Kinases.
  1. Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8+ T cells. Eur J Immunol. 2020 09; 50(9):1386-1399.
    View in: PubMed
    Score: 0.179
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.